13F HOLDINGS REPORT
RA CAPITAL MANAGEMENT, L.P.
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0001104659-25-049549
Total Value
$5.99B
Positions
86
Other Managers
0
Confidential Omitted
No
Holdings (86)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ASCENDIS PHARMA A/S - ADR | ASND | 10,281,496 | $1.60B | 26.76% |
| 2 | VAXCYTE INC | PCVX | 12,189,149 | $460.3M | 7.69% |
| 3 | RHYTHM PHARMACEUTICALS INC | RYTM | 6,084,412 | $322.3M | 5.38% |
| 4 | JANUX THERAPEUTICS INC | JANX | 11,189,693 | $302.1M | 5.05% |
| 5 | NEWAMSTERDAM PHARMA CO NV | NAMSW | 10,138,938 | $207.5M | 3.47% |
| 6 | ARCELLX INC | ACLX | 3,036,527 | $199.2M | 3.33% |
| 7 | EDGEWISE THERAPEUTICS INC | EWTX | 8,909,091 | $196.0M | 3.27% |
| 8 | AVIDITY BIOSCIENCES INC | 05370A108 | 6,300,408 | $186.0M | 3.11% |
| 9 | WAVE LIFE SCIENCES LTD | WVE | 18,202,009 | $147.1M | 2.46% |
| 10 | 89BIO INC | 282559103 | 19,889,683 | $144.6M | 2.41% |
| 11 | ARS PHARMACEUTICALS INC | SPRY | 10,860,977 | $136.6M | 2.28% |
| 12 | SIONNA THERAPEUTICS INC | SION | 10,445,322 | $109.3M | 1.82% |
| 13 | LENZ THERAPEUTICS INC | LENZ | 4,178,823 | $107.4M | 1.79% |
| 14 | DYNE THERAPEUTICS INC | DYN | 9,714,392 | $101.6M | 1.70% |
| 15 | TYRA BIOSCIENCES INC | TYRA | 10,637,290 | $98.9M | 1.65% |
| 16 | MINERALYS THERAPEUTICS INC | MLYS | 6,147,280 | $97.6M | 1.63% |
| 17 | GERON CORP | GERN | 60,379,366 | $96.0M | 1.60% |
| 18 | RXSIGHT INC | RXST | 3,743,018 | $94.5M | 1.58% |
| 19 | BICARA THERAPEUTICS INC | BCAX | 6,955,993 | $90.6M | 1.51% |
| 20 | DISC MEDICINE INC | IRON | 1,577,106 | $78.3M | 1.31% |
| 21 | GH RESEARCH PLC | GHRS | 6,944,648 | $76.6M | 1.28% |
| 22 | APOGEE THERAPEUTICS INC | APGE | 1,569,491 | $58.6M | 0.98% |
| 23 | DIANTHUS THERAPEUTICS INC | DNTH | 2,866,733 | $52.0M | 0.87% |
| 24 | ZAI LAB LTD-ADR | ZLAB | 1,295,040 | $46.8M | 0.78% |
| 25 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 5,755,577 | $45.6M | 0.76% |
| 26 | SEPTERNA INC | SEPN | 6,995,858 | $40.5M | 0.68% |
| 27 | TOURMALINE BIO INC | 89157D105 | 2,538,925 | $38.6M | 0.64% |
| 28 | SCHOLAR ROCK HOLDING CORP | SRRK | 1,136,453 | $36.5M | 0.61% |
| 29 | UROGEN PHARMA LTD | URGN | 3,206,271 | $35.5M | 0.59% |
| 30 | CLIMB BIO INC | CLYM | 28,939,395 | $35.3M | 0.59% |
| 31 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 9,853,302 | $29.6M | 0.49% |
| 32 | FULCRUM THERAPEUTICS INC | FULC | 10,229,099 | $29.5M | 0.49% |
| 33 | VOR BIOPHARMA INC | VOR | 39,646,039 | $28.4M | 0.48% |
| 34 | ASTRIA THERAPEUTICS INC | 04635X102 | 5,105,213 | $27.3M | 0.46% |
| 35 | KURA ONCOLOGY INC | KURA | 4,004,610 | $26.4M | 0.44% |
| 36 | STRUCTURE THERAPEUTICS INC | GPCR | 1,517,418 | $26.3M | 0.44% |
| 37 | CIDARA THERAPEUTICS INC | 171757206 | 1,092,796 | $23.5M | 0.39% |
| 38 | AEROVATE THERAPEUTICS INC | 008064107 | 9,192,092 | $23.1M | 0.39% |
| 39 | IDEAYA BIOSCIENCES INC | IDYA | 1,347,252 | $22.1M | 0.37% |
| 40 | ITEOS THERAPEUTICS INC | 46565G104 | 3,649,057 | $21.8M | 0.36% |
| 41 | TRAVERE THERAPEUTICS INC | TVTX | 1,150,000 | $20.6M | 0.34% |
| 42 | NKARTA INC | NKTX | 10,805,129 | $19.9M | 0.33% |
| 43 | GLAUKOS CORP | GKOS | 190,256 | $18.7M | 0.31% |
| 44 | MONOPAR THERAPEUTICS INC | MNPR | 511,207 | $18.6M | 0.31% |
| 45 | METSERA INC | 59267L107 | 675,525 | $18.4M | 0.31% |
| 46 | EYEPOINT PHARMACEUTICALS INC | EYPT | 3,181,818 | $17.2M | 0.29% |
| 47 | 10X GENOMICS INC-CLASS A | TXG | 1,944,247 | $17.0M | 0.28% |
| 48 | ACRIVON THERAPEUTICS INC | ACRV | 8,340,508 | $16.9M | 0.28% |
| 49 | ENLIVEN THERAPEUTICS INC | ELVN | 848,986 | $16.7M | 0.28% |
| 50 | ACUMEN PHARMACEUTICALS INC | ABOS | 14,932,063 | $16.4M | 0.27% |
| 51 | SOLID BIOSCIENCES INC | SLDB | 4,330,446 | $16.0M | 0.27% |
| 52 | CERIBELL INC | CBLL | 824,582 | $15.8M | 0.26% |
| 53 | NURIX THERAPEUTICS INC | NRIX | 1,333,333 | $15.8M | 0.26% |
| 54 | INSMED INC | INSM | 200,000 | $15.3M | 0.25% |
| 55 | TAYSHA GENE THERAPIES INC | TSHA | 10,872,503 | $15.1M | 0.25% |
| 56 | PEPGEN INC | PEPG | 10,689,545 | $15.0M | 0.25% |
| 57 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 4,563,211 | $14.7M | 0.25% |
| 58 | PROTARA THERAPEUTIC INC | TARA | 3,400,000 | $14.5M | 0.24% |
| 59 | LARIMAR THERAPEUTICS INC | LRMR | 6,045,351 | $13.0M | 0.22% |
| 60 | ELEDON PHARMACEUTICALS INC | ELDN | 3,566,338 | $12.1M | 0.20% |
| 61 | ALECTOR INC | ALEC | 9,695,228 | $11.9M | 0.20% |
| 62 | SERA PROGNOSTICS INC-A | SERA | 3,032,808 | $11.2M | 0.19% |
| 63 | MBX BIOSCIENCES INC | MBX | 1,511,334 | $11.2M | 0.19% |
| 64 | BICYCLE THERAPEUTICS PLC-ADR | BCYC | 1,093,477 | $9.3M | 0.16% |
| 65 | ARCUS BIOSCIENCES INC | RCUS | 1,136,364 | $8.9M | 0.15% |
| 66 | SURROZEN INC | SRZNW | 679,130 | $7.9M | 0.13% |
| 67 | IMMATICS NV | IMTX | 1,750,000 | $7.9M | 0.13% |
| 68 | AVALO THERAPEUTICS INC | AVTX | 967,000 | $7.7M | 0.13% |
| 69 | PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | 750,000 | $7.7M | 0.13% |
| 70 | Bright Minds Biosciences Inc | DRUG | 206,427 | $7.4M | 0.12% |
| 71 | ACLARIS THERAPEUTICS INC | ACRS | 4,666,667 | $7.1M | 0.12% |
| 72 | ACADIA HEALTHCARE CO INC | ACHC | 217,000 | $6.6M | 0.11% |
| 73 | BETA BIONICS INC | BBNX | 500,000 | $6.1M | 0.10% |
| 74 | XENCOR INC | XNCR | 575,000 | $6.1M | 0.10% |
| 75 | WEREWOLF THERAPEUTICS INC | HOWL | 6,144,881 | $6.0M | 0.10% |
| 76 | ADICET BIO INC | ACET | 7,541,000 | $5.7M | 0.10% |
| 77 | HUMACYTE INC | HUMAW | 3,312,356 | $5.6M | 0.09% |
| 78 | ZURA BIO LTD | ZURA | 3,217,503 | $4.2M | 0.07% |
| 79 | BIOAGE LABS INC | BIOA | 1,052,494 | $4.0M | 0.07% |
| 80 | BOUNDLESS BIO INC | BOLD | 2,180,631 | $3.3M | 0.05% |
| 81 | CLIMB BIO INC | CLYM | 2,479,872 | $3.0M | 0.05% |
| 82 | NEWAMSTERDAM PHARMA CO NV-27 | NAMSW | 333,333 | $3.0M | 0.05% |
| 83 | SUTRO BIOPHARMA INC | STRO | 4,434,637 | $2.9M | 0.05% |
| 84 | LEXEO THERAPEUTICS INC | LXEO | 546,554 | $1.9M | 0.03% |
| 85 | CYTOMX THERAPEUTICS INC | CTMX | 1,000,000 | $635,800 | 0.01% |
| 86 | SCILEX HOLDING CO | SCLXW | 1,036,218 | $257,500 | 0.00% |